兽用疫苗市场规模、份额、成长分析、按产品、给药途径和地区 - 产业预测，2024-2031 年

2022年全球兽用疫苗市场规模为124亿美元，从2023年的135.9亿美元成长到2031年的283亿美元，复合年增长率预计为9.60%。

动物疾病发病率的增加以及牲畜数量的增加极大地促进了反刍动物疫苗，特别是牛疫苗的全球采用。由于牲畜对于肉类、牛奶、羊毛和皮革的生产至关重要，因此迫切需要接种疫苗来预防损害牲畜健康和生产力的疾病，例如狂犬病、马流感和口蹄疫。对粮食安全的日益担忧和畜牧业产量的激增进一步推动了对这些疫苗的需求。随着消费者偏好随着人口成长而变化，对畜产品的需求也在改变。此外，疫苗技术的进步和疾病的频繁爆发正在重塑市场动态，并促进牲畜疫苗产业的持续扩张。

目录

介绍

• 研究目的
• 调查范围
• 定义

调查方法

• 资讯采购
• 二手资料和主要资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 按细分市场的机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 抑制因素和挑战
• 波特分析与影响
  • 竞争公司之间的敌对关係
  • 替代品的威胁
  • 买方议价能力
  • 新进入者的威胁
  • 供应商的议价能力

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2023）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 价格分析
• 技术进步
• 监管环境
• 专利分析
• 案例研究

动物疫苗市场规模：依产品分类

• 市场概况
• 减毒活病毒疫苗
• 灭活疫苗
• 次单位疫苗
• DNA疫苗
• 重组疫苗

兽用疫苗市场规模：依给药途径划分

• 市场概况
• 皮下的
• 肌肉注射
• 鼻内

动物疫苗市场规模：依动物类型

• 市场概况
• 家畜
  • 家禽
  • 鱼
  • 反刍动物
  • 猪
• 伴同性
  • 狗
  • 猫科动物
  • 其他的

动物疫苗市场规模：依分销管道分类

• 市场概况
• 零售
• 电子商务
• 医院/诊所药房

动物疫苗市场规模：按地区

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 英国
  • 德国
  • 西班牙
  • 法国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东/非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东/非洲

竞争资讯

• 前5名企业对比
• 主要企业市场定位（2023年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2023）
• 主要企业简介
  • 公司简介
  • 产品系列分析
  • 按细分市场分類的份额分析
  • 收益与前一年同期比较（2021-2023）

主要企业简介

• Zoetis
• Merck & Co., Inc.
• Boehringer Ingelheim International GmbH
• Elanco Animal Health Inc.
• Bayer AG
• Virbac
• Ceva
• HIPRA
• Hester Biosciences Limited
• Biogenesis Bago
• Vaxxinova
• IDT Biologika GmbH
• Bimeda Animal Health
• BravoVax
• MSD Animal Health
• Agrovet Market Animal Health
• Anicon Labor GmbH

结论和建议

Global Animal Vaccines Market size was valued at USD 12.4 billion in 2022 and is poised to grow from USD 13.59 billion in 2023 to USD 28.30 billion by 2031, growing at a CAGR of 9.60% during the forecast period (2024-2031).

The rising incidence of animal diseases, coupled with a growing livestock population, is significantly boosting the global acceptance of ruminant vaccines, especially for cattle. With animals being vital for producing meat, milk, wool, and leather, there is an increased urgency for vaccination to prevent diseases like rabies, equine influenza, and foot-and-mouth disease that compromise animal health and productivity. The escalating concerns surrounding food security and the surge in animal husbandry practices are further driving demand for these vaccines. As consumer preferences evolve alongside population growth, the appetite for livestock products intensifies. Moreover, advancements in vaccine technology and frequent disease outbreaks are reshaping market dynamics, contributing to continued expansion in the livestock vaccination sector.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Animal Vaccines market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Animal Vaccines Market Segmental Analysis

Global Animal Vaccines Market is segmented by Product, Route of Administration, Animal Type, Distribution Channel, and region. Based on Product, the market is segmented into Attenuated Live Vaccines, Inactivated Vaccines, Subunit Vaccines, DNA Vaccines, and Recombinant Vaccines. Based on Route of Administration, the market is segmented into Subcutaneous, Intramuscular, and Intranasal. Based on Animal Type, the market is segmented into Livestock, and Companion Based on Distribution Channel, the market is segmented into Retail, E-Commerce, and Hospital/ Clinic Pharmacy. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Animal Vaccines Market

The Global Animal Vaccines market is significantly driven by the rising incidence of zoonotic diseases, which have a detrimental impact on human health and underscore the urgent need for effective animal immunization. The escalating threat posed by emerging and exotic diseases compromises not only human and animal well-being but also jeopardizes food security. With increasing human and animal populations, coupled with environmental changes and the globalization of trade and travel, there are heightened risks for pathogen transmission across species. Furthermore, advancements in technology have transformed animal vaccination practices, leading to substantial R&D breakthroughs. Traditional vaccination methods have paved the way for the development of recombinant vaccines, which offer enhanced safety benefits by eliminating exposure to live pathogens. These dynamics collectively drive the demand for innovative animal vaccines in today's market.

Restraints in the Global Animal Vaccines Market

The Global Animal Vaccines market faces significant constraints, particularly in developing regions such as Africa, Asia, and Latin America, where an estimated 600-900 million smallholder farmers manage livestock. The adoption of animal vaccinations among these farmers is hindered by multiple challenges, including a lack of awareness regarding the advantages of vaccination, financial limitations that prevent access to immunization products, and the inadequate supply chain that restricts availability. As a result, many livestock animals owned by smallholder farmers succumb to various diseases, leading to further economic hardships for these communities. Governments and organizations are implementing strategies to enhance the accessibility, availability, and affordability of animal vaccination to improve livestock health in these areas.

Market Trends of the Global Animal Vaccines Market

The Global Animal Vaccines market is poised for substantial growth, driven by a surge in public-private funding for targeted research initiatives and a heightened prevalence of animal diseases. Technological advancements are facilitating product innovations, presenting lucrative opportunities for market players. Future growth will be further supported by increasing strategic alliances, enhanced internet penetration, and heightened concerns regarding zoonotic diseases. Additionally, advancements in diagnostics and therapeutics in developing regions, coupled with rising per capita healthcare spending, will amplify market demand. Collectively, these factors are positioning the animal vaccines sector as a critical market trend in the evolving landscape of veterinary healthcare.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Driver & Opportunities
  • Restraints & Challenges
• Porters Analysis & Impact
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2023
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technological Advancement
• Regulatory Landscape
• Patent Analysis
• Case Studies

Global Animal Vaccines Market Size by Product & CAGR (2024-2031)

• Market Overview
• Attenuated Live Vaccines
• Inactivated Vaccines
• Subunit Vaccines
• DNA Vaccines
• Recombinant Vaccines

Global Animal Vaccines Market Size by Route of Administration & CAGR (2024-2031)

• Market Overview
• Subcutaneous
• Intramuscular
• Intranasal

Global Animal Vaccines Market Size by Animal Type & CAGR (2024-2031)

• Market Overview
• Livestock
  • Poultry
  • Aqua
  • Ruminants
  • Swine
• Companion
  • Canine
  • Feline
  • Others

Global Animal Vaccines Market Size by Distribution Channel & CAGR (2024-2031)

• Market Overview
• Retail
• E-Commerce
• Hospital/ Clinic Pharmacy

Global Animal Vaccines Market Size & CAGR (2024-2031)

• North America, (Product, Route of Administration, Animal Type, Distribution Channel)
  • US
  • Canada
• Europe, (Product, Route of Administration, Animal Type, Distribution Channel)
  • UK
  • Germany
  • Spain
  • France
  • Italy
  • Rest of Europe
• Asia-Pacific, (Product, Route of Administration, Animal Type, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America, (Product, Route of Administration, Animal Type, Distribution Channel)
  • Brazil
  • Rest of Latin America
• Middle East & Africa, (Product, Route of Administration, Animal Type, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Zoetis
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck & Co., Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boehringer Ingelheim International GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Elanco Animal Health Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Virbac
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ceva
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HIPRA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hester Biosciences Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biogenesis Bago
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vaxxinova
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IDT Biologika GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bimeda Animal Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BravoVax
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MSD Animal Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agrovet Market Animal Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Anicon Labor GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendation